INmune Bio, Inc. (NASDAQ:INMB) Q3 2023 Earnings Call Transcript November 1, 2023 INmune Bio, Inc. beats earnings expectations. Reported EPS is $-0.00048, expectations were $-0.39. Operator: Greetings and welcome to the INmune Bio Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal […]
Analysts at Robert W. Baird initiated coverage on shares of INmune Bio (NASDAQ:INMB – Get Rating) in a note issued to investors on Wednesday, The Fly reports. The firm set an “outperform” rating on the stock. INmune Bio Stock Down 3.7 % Shares of INMB traded down $0.29 during mid-day trading on Wednesday, reaching $7.58. […]
Analysts at Robert W. Baird initiated coverage on shares of INmune Bio (NASDAQ:INMB – Get Rating) in a note issued to investors on Wednesday, The Fly reports. The firm set an “outperform” rating on the stock. INmune Bio Stock Down 3.7 % Shares of INMB traded down $0.29 during mid-day trading on Wednesday, reaching $7.58. […]
Presidential Plenary Lecture to be Presented Wednesday, May 31 at the ICST Opening Session BOCA RATON, Fla., May 24, 2023 INmune Bio Inc. announces that Mark Lowdell,. | June 11, 2023
Represents First Ever Natural Killer Immunotherapy trial in Metastatic Castration-Resistant Prostate CancerWebinar at 11AM ET on Friday, May 12. BOCA RATON, Fla., May 08, 2023 . | May 8, 2023